The Oslo Acute Reperfusion Stroke Study (OSCAR)

Acute Ischemic Stroke Clinical Trial

— OSCAR  

Official title:

The Oslo Acute Reperfusion Stroke Study (OSCAR)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06220981
• Other study ID #: 2015-17637
• Status: Recruiting
• Start date: January 10, 2017
• Est. completion date: December 31, 2025

Study information

• Verified date: January 2024
• Source: Oslo University Hospital
• Contact: Anne Hege Aamodt
• Phone: 97417734
• Email: anne.hege.aamodt[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Prospective registry of clinical and radiological data in acute ischemic stroke patients after endovascular treatment.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1500
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2025
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 years or older

• Patients with ischemic stroke and cerebral arterial occlusion treated with endovascular revascularization.

• All stroke severities and vascular distributions are eligible.

• Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines.

Exclusion criteria:

• Patient not eligible for the study or not available for follow-up assessments (e.g. non- resident).

Related Conditions & MeSH terms

• Acute Ischemic Stroke
• Ischemic Stroke
• Stroke

Intervention

Other:
• Endovascular treatment

Locations

Country	Name	City	State
Norway	Oslo University Hospital	Oslo

Sponsors (1)

Lead Sponsor	Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modified Rankin Scale Score	Modified Rankin Scale Score (mRS), min 0, max 6	3 months
Secondary	National Institute of Health Stroke Scale Score	National Institute of Health Stroke Scale Score (NIHSS, min 0, max 42)	discharge
Secondary	Death due to any cause	Mortality	3 months
Secondary	Infarct volume	Infarct volume (ml)	1 day
Secondary	Incidence of symptomatic intracranial hemorrhage	Incidence of symptomatic intracranial hemorrhage (SICH)	1 day
Secondary	Volume of new areas of diffusion restriction	Volume of new areas of diffusion restriction	1 day
Secondary	serious adverse events	serious adverse events	3 months